Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Rating of “Hold” from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has earned an average rating of “Hold” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $5.81.

A number of analysts recently weighed in on the stock. Robert W. Baird lowered their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. BTIG Research began coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective on the stock. Morgan Stanley reduced their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research note on Friday, August 9th.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.67 on Wednesday. The firm has a market cap of $539.48 million, a price-to-earnings ratio of -1.51, a PEG ratio of 3.50 and a beta of 1.40. The company has a 50 day moving average of $4.37 and a 200-day moving average of $4.77. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Institutional Investors Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DH. Barclays PLC increased its stake in shares of Definitive Healthcare by 318.8% during the 3rd quarter. Barclays PLC now owns 81,916 shares of the company’s stock worth $366,000 after purchasing an additional 62,354 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Definitive Healthcare during the 3rd quarter worth about $93,000. State Street Corp increased its stake in shares of Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares during the last quarter. Point72 DIFC Ltd increased its stake in shares of Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after purchasing an additional 8,215 shares during the last quarter. Finally, Centiva Capital LP acquired a new position in shares of Definitive Healthcare during the 3rd quarter worth about $185,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.